Webster C - Search Results

1

The value, qualification, and regulatory use of surrogate end points in drug development.

Lathia CD, Amakye D, Dai W, Girman C, Madani S, Mayne J, MacCarthy P, Pertel P, Seman L, Stoch A, Tarantino P, Webster C, Williams S, Wagner JA. Lathia CD, et al. Among authors: webster c. Clin Pharmacol Ther. 2009 Jul;86(1):32-43. doi: 10.1038/clpt.2009.69. Epub 2009 May 27. Clin Pharmacol Ther. 2009. PMID: 19474783 Review.

2

Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs.

Wagner JA, Williams SA, Webster CJ. Wagner JA, et al. Among authors: webster cj. Clin Pharmacol Ther. 2007 Jan;81(1):104-7. doi: 10.1038/sj.clpt.6100017. Clin Pharmacol Ther. 2007. PMID: 17186007

3

A cost-effectiveness approach to the qualification and acceptance of biomarkers.

Williams SA, Slavin DE, Wagner JA, Webster CJ. Williams SA, et al. Nat Rev Drug Discov. 2006 Nov;5(11):897-902. doi: 10.1038/nrd2174. Nat Rev Drug Discov. 2006. PMID: 17080026 Review.

4

A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.

Wendt J, Cady R, Singer R, Peters K, Webster C, Kori S, Byrd S. Wendt J, et al. Among authors: webster c. Clin Ther. 2006 Apr;28(4):517-26. doi: 10.1016/j.clinthera.2006.03.013. Clin Ther. 2006. PMID: 16750463 Clinical Trial.

5

The drug diagnostic co-development concept paper: commentary from the 3rd FDA-DIA-PWG-PhRMA-BIO Pharmacogenomics Workshop.

Hinman LM, Huang SM, Hackett J, Koch WH, Love PY, Pennello G, Torres-Cabassa A, Webster C. Hinman LM, et al. Among authors: webster c. Pharmacogenomics J. 2006 Nov-Dec;6(6):375-80. doi: 10.1038/sj.tpj.6500392. Epub 2006 May 2. Pharmacogenomics J. 2006. PMID: 16652120 Review.

6

Efficacy of subcutaneous sumatriptan in repeated episodes of migraine.

Cady RK, Dexter J, Sargent JD, Markley H, Osterhaus JT, Webster CJ. Cady RK, et al. Among authors: webster cj. Neurology. 1993 Jul;43(7):1363-8. doi: 10.1212/wnl.43.7.1363. Neurology. 1993. PMID: 8392150 Clinical Trial.

7

Efficacy and tolerability of subcutaneous sumatriptan for acute migraine: a comparison between ethnic groups.

Burke-Ramirez P, Asgharnejad M, Webster C, Davis R, Laurenza A. Burke-Ramirez P, et al. Among authors: webster c. Headache. 2001 Oct;41(9):873-82. Headache. 2001. PMID: 11703474 Clinical Trial.

8

Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.

Winner P, Rothner AD, Wooten JD, Webster C, Ames M. Winner P, et al. Among authors: webster c. Headache. 2006 Feb;46(2):212-22. doi: 10.1111/j.1526-4610.2006.00339.x. Headache. 2006. PMID: 16492230 Clinical Trial.

9

Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.

Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M. Ishkanian G, et al. Clin Ther. 2007 Jan;29(1):99-109. doi: 10.1016/j.clinthera.2007.01.012. Clin Ther. 2007. PMID: 17379050 Clinical Trial.

10

Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.

Natarajan S, Jabbour JT, Webster CJ, Richardson MS. Natarajan S, et al. Headache. 2004 Nov-Dec;44(10):969-77. doi: 10.1111/j.1526-4610.2004.04190.x. Headache. 2004. PMID: 15546259 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,024 results

Search Page